FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry. Presented is a prophylactic or therapeutic agent for itching caused by IL-31, which as an active substance contains an effective amount of anti-NR10 antibody possessing neutralizing activity with respect to NR10, as well as pharmaceutically acceptable additives. Also proposed is a method of treating or preventing itching caused by IL-31, which involves the stage of administering the above anti-NR10 antibody. Invention also relates to the use of the said anti-NR10 antibody for preparing therapeutic or preventive agent for itching caused by IL-31.
EFFECT: invention allows to suppress itching induced by IL-31.
5 cl, 5 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR ITCHING | 2008 |
|
RU2541780C2 |
| NR10 ANTIBODY AND USING IT | 2008 |
|
RU2531521C2 |
| ANTIBODY AGAINST NR10 AND ITS APPLICATION | 2009 |
|
RU2487136C2 |
| PREVENTIVE AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE | 2007 |
|
RU2511406C2 |
| ANTIBODY AGAINST HUMAN FN14 | 2019 |
|
RU2787044C2 |
| HETERODIMERIC BISPECIFIC ANTIBODY AGAINST TNFα/AGAINST IL-17A, SIMILAR BY STRUCTURE TO NATURAL ANTIBODY, AND ITS PRODUCTION METHOD | 2019 |
|
RU2781816C1 |
| IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USING | 2006 |
|
RU2444528C2 |
| METHODS FOR TREATING CANCER, INCLUDING TIGIT-BINDING AGENTS | 2017 |
|
RU2765410C2 |
| ADVANCED ANTIBODY MOLECULES | 2009 |
|
RU2430111C1 |
| NOVEL ANTI-PD-L1 ANTIBODIES | 2016 |
|
RU2736151C2 |
